Division of Nephrology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Nephrol Dial Transplant. 2010 Sep;25(9):2908-21. doi: 10.1093/ndt/gfq183. Epub 2010 Apr 12.
Recent studies provided evidence of the potential role of CD11c(+) F4/80(+) dendritic subset in mediating injury and repair. The purpose of this study was to examine the role of kidney CD11c(+) F4/80(+) dendritic subset in the recovery phase of ischaemia/reperfusion injury (IRI).
Following ischaemia/reperfusion (I/R), liposome clodronate or phosphate buffered saline (PBS) was administered, and on day 7 biochemical and histologic kidney damage was assessed. Activation and depletion of CD11c(+) F4/80(+) dendritic subset were confirmed by flow cytometry. Isolation of kidney CD11c(+) cells on days 1 and 7 with in vitro culture for measuring cytokines was performed to define functional characteristics of these cells, and adoptive transfer of CD11c(+) cells was also done.
Following kidney IRI, the percentage of CD11c(+) F4/80(+) kidney dendritic cell subset that co-expresses maturation marker increased. Liposome clodronate injection after I/R resulted in preferential depletion of CD11c(+) F4/80(+) kidney dendritic subset, and depletion of these cells was associated with persistent kidney injury, more apoptosis, inflammation and impaired tubular cell proliferation. CD11c(+) F4/80(+) cell depletion was also associated with higher tissue levels of pro-inflammatory cytokines and lower level of IL-10, indicating the persistence of inflammatory milieu. Isolated kidney CD11c(+) cells on day 7 showed different phenotype with increased production of IL-10 compared with those on day 1. Adoptive transfer of CD11c(+) cells partially reversed impaired tissue recovery.
Our results suggest that kidney CD11c(+) F4/80(+) dendritic subset might contribute to the recovery process by dynamic phenotypic change from pro-inflammatory to anti-inflammatory with modulation of immune response.
最近的研究表明 CD11c(+)F4/80(+)树突状细胞亚群在介导损伤和修复中具有潜在作用。本研究旨在探讨肾 CD11c(+)F4/80(+)树突状细胞亚群在缺血/再灌注损伤 (IRI) 恢复阶段的作用。
在发生缺血/再灌注 (I/R) 后,给予脂质体氯膦酸盐或磷酸盐缓冲液 (PBS),并在第 7 天评估生化和组织学肾损伤。通过流式细胞术证实 CD11c(+)F4/80(+)树突状细胞亚群的激活和耗竭。在第 1 天和第 7 天通过体外培养分离肾 CD11c(+)细胞以测量细胞因子,以确定这些细胞的功能特征,并进行 CD11c(+)细胞的过继转移。
在肾 IRI 后,表达成熟标志物的 CD11c(+)F4/80(+)肾树突状细胞亚群的比例增加。I/R 后注射脂质体氯膦酸盐导致 CD11c(+)F4/80(+)肾树突状细胞亚群优先耗竭,并且这些细胞的耗竭与持续的肾损伤、更多的细胞凋亡、炎症和肾小管细胞增殖受损有关。CD11c(+)F4/80(+)细胞耗竭也与组织中促炎细胞因子水平升高和 IL-10 水平降低有关,表明炎症环境持续存在。与第 1 天相比,第 7 天分离的肾 CD11c(+)细胞表现出不同的表型,产生的 IL-10 增加。CD11c(+)细胞的过继转移部分逆转了组织恢复受损。
我们的结果表明,肾 CD11c(+)F4/80(+)树突状细胞亚群可能通过从促炎到抗炎的动态表型变化来促进组织恢复,并调节免疫反应。